Editor’s note: This is a developing story. Please check back soon for comments.The FDA approved Enspryng, an interleukin-6 inhibitor, for at-home subcutaneous treatment of thyroid eye disease, according to a press release from Genentech.The approval wa…
Cortical visual impairment is the leading cause of blindness in children in the developed world and is increasing in incidence. Medscape Medical News
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)—- $RHHBY–Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Enspryng® (satralizumab-mwge) for the treatment …
NEW ORLEANS — Oku Digital Health, which was recently launched from Topcon Healthcare, will use a network of more than 10,000 healthcare locations for early disease detection through routine eye exams, according to a press release.Oculomics is the use o…
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the third quarter ended September 30, 2026, will be released befor…
NEW ORLEANS — Verily Health has partnered with Bausch + Lomb to expand Verily Me, its consumer health app, into eye health for the first time.The launch adds personalized risk and symptom education, an AI-guided symptom conversation with AI agent “Vi,”…